The plasminogen activator/plasmin system.
暂无分享,去创建一个
[1] J. Saurat,et al. Differential protease expression by cutaneous squamous and basal cell carcinomas. , 1991, The Journal of clinical investigation.
[2] F. Blasi,et al. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. , 1991, The American journal of pathology.
[3] L. Orci,et al. Plasminogen activator inhibitor-1 is induced in microvascular endothelial cells by a chondrocyte-derived transforming growth factor-beta. , 1991, Biochemical and biophysical research communications.
[4] J. Calvete,et al. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). , 1991, The Journal of biological chemistry.
[5] D. Belin,et al. Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. , 1991, The Journal of clinical investigation.
[6] H. Chapman,et al. An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. , 1991, The Journal of clinical investigation.
[7] Jordi Félez,et al. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. , 1991, Biochemistry.
[8] K. Preissner,et al. Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin. , 1991, Biochemistry.
[9] P. Gaffney,et al. Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor. , 1991, Biochemistry.
[10] F. Blasi,et al. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. , 1991, The Journal of biological chemistry.
[11] L. Orci,et al. Chondrocytes inhibit endothelial sprout formation in vitro: Evidence for involvement of a transforming growth factor‐beta , 1991, Journal of cellular physiology.
[12] A. Vaheri,et al. Plasminogen activation at the cell surface-matrix interface. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.
[13] J. Quigley,et al. Serine protease and metallo protease cascade systems involved in pericellular proteolysis. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.
[14] R. Montesano,et al. Proteolytic balance and capillary morphogenesis. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.
[15] L. Lund,et al. The urokinase receptor and regulation of cell surface plasminogen activation. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.
[16] J. Mimuro,et al. Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.
[17] E. Plow,et al. Plasminogen receptors in the mediation of pericellular proteolysis. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.
[18] P. Dennis,et al. Growth factor control of extracellular proteolysis. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.
[19] P. Rørth,et al. Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester. , 1990, Nucleic acids research.
[20] R. Medcalf,et al. A DNA motif related to the cAMP-responsive element and an exon-located activator protein-2 binding site in the human tissue-type plasminogen activator gene promoter cooperate in basal expression and convey activation by phorbol ester and cAMP. , 1990, The Journal of biological chemistry.
[21] L. Orci,et al. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro , 1990, The Journal of cell biology.
[22] L. Orci,et al. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes , 1990, The Journal of cell biology.
[23] K. Danø,et al. Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. , 1990, The Journal of biological chemistry.
[24] W. Fiers,et al. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. , 1990, Blood.
[25] D. von der Ahe,et al. Macromolecular interaction on a cAMP responsive region in the urokinase-type plasminogen activator gene: a role of protein phosphorylation. , 1990, Nucleic acids research.
[26] K. Hajjar,et al. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. , 1990, The Journal of biological chemistry.
[27] S. Stacey,et al. Plasminogen activator inhibitors: hormonally regulated serpins , 1990, Molecular and Cellular Endocrinology.
[28] T. V. van Berkel,et al. Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells. , 1990, Thrombosis research. Supplement.
[29] Disease,et al. Serine Proteases and Their Serpin Inhibitors in the Nervous System , 1990, NATO ASI Series.
[30] D. Belin,et al. Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2. , 1989, The EMBO journal.
[31] D. Belin,et al. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos , 1989, The Journal of cell biology.
[32] N. Seeds,et al. Characterization of 125I-tissue plasminogen activator binding to cerebellar granule neurons , 1989, The Journal of cell biology.
[33] A. Eisen,et al. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Scully,et al. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. , 1989, The Journal of biological chemistry.
[35] D. Belin,et al. Characterization of the cellular binding site for the urokinase-type plasminogen activator. , 1989, The Journal of biological chemistry.
[36] A. Hsueh,et al. Suppression of ovulation rate by antibodies to tissue-type plasminogen activator and alpha 2-antiplasmin. , 1989, Endocrinology.
[37] L. Ossowski,et al. In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase , 1988, The Journal of cell biology.
[38] J. Sambrook,et al. Variants of human tissue‐type plasminogen activator that lack specific structural domains of the heavy chain. , 1988, The EMBO journal.
[39] L. Lund,et al. One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity. , 1988, The Journal of biological chemistry.
[40] D. Belin,et al. Meiotic maturation of mouse oocytes triggers the translation and polyadenylation of dormant tissue-type plasminogen activator mRNA. , 1987, Genes & development.
[41] D. Belin,et al. Modulations of functional activity in differentiated macrophages are accompanied by early and transient increase or decrease in c-fos gene transcription. , 1987, Journal of immunology.
[42] D. Belin,et al. Plasminogen activator and mouse spermatozoa: urokinase synthesis in the male genital tract and binding of the enzyme to the sperm cell surface , 1987, The Journal of cell biology.
[43] L. Ossowski,et al. Human neutrophil plasminogen activator is localized in specific granules and is translocated to the cell surface by exocytosis , 1986, The Journal of experimental medicine.
[44] S. Strickland,et al. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen. , 1986, Biochemistry.
[45] D. Belin,et al. Plasminogen activator in mouse and rat oocytes: Induction during meiotic maturation , 1985, Cell.
[46] D. Belin,et al. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase , 1985, The Journal of cell biology.
[47] K. Danø,et al. Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.
[48] K. Danø,et al. Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse , 1984, The Journal of cell biology.
[49] D. Rifkin,et al. Down-regulation of epidermal growth factor receptor correlates with plasminogen activator activity in human A431 epidermoid carcinoma cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. Valinsky,et al. Plasminogen activator in the bursa of Fabricius: Correlations with morphogenetic remodeling and cell migrations , 1981, Cell.